Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study. [electronic resource]
Producer: 20181001Description: 494-500 p. digitalISSN:- 1477-092X
- Aged
- Aged, 80 and over
- Anticoagulants -- therapeutic use
- Enoxaparin -- therapeutic use
- Factor Xa Inhibitors -- therapeutic use
- Female
- Hemorrhage -- chemically induced
- Heparin, Low-Molecular-Weight -- therapeutic use
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Pyrazoles -- therapeutic use
- Pyridones -- therapeutic use
- Recurrence
- Retrospective Studies
- Rivaroxaban -- therapeutic use
- Secondary Prevention
- Venous Thromboembolism -- drug therapy
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.